Features May 2015 Issue

Study Shows Long-term Benefits of TAVR Over Medical Therapy

In TAVR, a catheter inserted through an artery delivers a replacement valve that is expanded and set in place by a balloon.

Study Shows Long-term Benefits of TAVR Over Medical Therapy

The minimally invasive procedure to replace a diseased aortic valve is proving to be a durable solution for high-risk patients.

Patients who have a stiff aortic valve replaced using a catheter procedure have better outcomes after five years than similar patients who undergo a catheter procedure that simply uses a small balloon to open the valve’s leaflets. Those are the findings of a Cleveland Clinic study published recently in The Lancet. Led by Samir Kapadia, MD, director of the Sones Cardiac Catheterization Laboratories at Cleveland Clinic, the study further supports the use of a promising new procedure called transcatheter aortic valve replacement (TAVR). It’s an option for patients who are too frail for open heart surgery. “This trial is the first—and will probably be the only—randomized aortic stenosis trial that includes a group of patients not treated with aortic valve replacement, since these results will make it unethical to treat severe stenosis patients with medical therapy alone,” Dr. Kapadia says.

To continue reading this article you must be a paid subscriber.

Subscribe to Heart Advisor

Get the next year of HEART ADVISOR for just $20. That's a savings of $19 off the regular rate.

With your paid subscription you will receive unlimited access to all of our online content. That is over a decade of previous issues from Cleveland Clinic, the hospital rated #1 in cardiac care by U.S. News & World Report - free of charge.

Subscriber Log In

Forgot your password? Click Here.

Already subscribe but haven't registered for all the benefits of the website? Click here.